Antischistosomal action of thioxo-imidazolidine compounds: An ultrastructural and cytotoxicity study

Experimental Parasitology

Volumn 128, Issue 1, 2011, Pages 82-90

  Neves, Juliana Kelle A L ^a   de Lima, Maria do Carmo Alves ^a   Pereira, Valéria Rego Alves ^b   de Melo, Cristiane Moutinho Lagos ^b   Peixoto, Christina Alves ^b   Pitta, Ivan da Rocha ^a   Albuquerque, Mônica Camelo Pessoa Azevedo ^c   Galdino, Suely Lins ^a  

^a DEPARTAMENTO DE MICOLOGIA   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Imidazolidinone derivatives; In vitro; Praziquantel; Schistosoma mansoni; Schistosomiasis

Indexed keywords

1 (4 CHLOROBENZYL) 4 [(4 FLUOROPHENYL)HYDRAZONO] 5 THIOXO IMIDAZOLIDIN 2 ONE; 1 BENZYL 4 [(4 CHLOROPHENYL)HYDRAZONO] 5 THIOXO IMIDAZOLIDIN 2 ONE; ANTHELMINTIC AGENT; IMIDAZOLINE DERIVATIVE; PRAZIQUANTEL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTHELMINTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL DEATH; CELL ULTRASTRUCTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; IN VITRO STUDY; MALE; MICROMORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; STRUCTURE ANALYSIS;

SCHISTOSOMA; SCHISTOSOMA MANSONI; VERMES;

EID: 79952897761     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2011.01.021     Document Type: Article

References (31)

1. Albuquerque M.C.A., Silva T.G., Pitta M.G.R., Silva A.C.A., Silva P.G., Malagueño E., Santana J.V., Wanderley A.G., Lima M.C.A., Galdino S.L., Barbe J., Pitta I.R. Synthesis and schistosomicidal activity of new substituted thioxoimidazolidine compounds. Pharmazie 2005, 60:13-17.
2. Badreldin H.A. A short review of some pharmacological, therapeutic and toxicological properties of praziquantel in man and animals. Pakistan Journal of Pharmaceutical Sciences 2006, 19:170-175.
3. Brandão S.S.F., Rocha Filho J.A., Chantegrel J., Albuquerque J.F.C., Ximenes E.A., Galdino S.L., Pitta I.R., Perrissin M., Luu-Duc C. Synthesis and structural study of substituted arylazo-imidazolidines and arylidenethiazolidines. Annales Pharmaceutiques Francaises 1997, 55:206-211.
4. Caterina M.C., Perillo I.A., Boiani L., Pezaroglo H., Cerecetto H., Gonzalez M., Salerno A. Imidazolidines as new anti-Trypanosoma cruzi agents: biological evaluation and structure-activity relationships. Bioorganic and Medicinal Chemistry 2008, 16:2226-2234.
5. Cioli D., Pica-Mattoccia L. Praziquantel. Parasitology Research 2003, 90:3-9.
6. Chitsulo L., Loverde P., Engels D. Schistosomiasis. Nature Reviews Microbiology 2004, 2:12-13.
7. Dayan A.D. Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. Acta Tropica 2003, 86:141-159.
8. Dias L.C., Dessoy M.A., Silva J.J.N., Thiemann O.H., Oliva G., Andricopulo A.D. Quimioterapia da doença de chagas: estado da arte e perspectivas no desenvolvimento de novos fármacos. Química Nova 2009, 15:1-14.
9. Dubois F., Caby S., Oger F., Cosseau C., Capron M., Grunau C., Dissous C., Histone Pierce.R.J. Deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni. Molecular and Biochemical Parasitology. 2009, 168:7-15.
10. Gryseels B., Polman K., Clerinx J., Kestens L. Human schistosomiasis. Lancet 2006, 368:1106-1118.
11. Ismail M., Botros S., Metwally A., William S., Farghally A., Tao L.F., Day T.A., Bennett J.L. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. American Journal of Tropical Medicine and Hygiene. 1999, 60:932-935.
12. Jiraungkoorskul W., Sahaphonga S., Sobhonc P., Riengrojpitaka S., Kangwanrangsan N. Effects of praziquantel and artesunate on the tegument of adult Schistosoma mekongi harboured in mice. Parasitology International. 2005, 54:177-183.
13. Jiraungkoorskul W., Sahaphong S., Sobhon P., Riengrojpitak S., Kangwanrangsan N. Schistosoma mekongi: the in vitro effect of praziquantel and artesunate on the adult fluke. Experimental Parasitology 2006, 113:16-23.
14. Malheiros S.V.P., Brito M.A., Brites D., Meirelles N.C. Membrane effects of trifluoperazine, dibucaine and praziquantel on human erythrocytes. Chemico-Biological Interactions 2000, 126:79-95.
15. Martin R.J. Mode of action of anthelminitic drugs. Veterinary Journal 1997, 154:11-34.
16. Neves J.K., Botelho S.P., de Melo C.M., Pereira V.R., de Lima Mdo C., Pitta Ida R., Albuquerque M.C., Galdino S.L. Biological and immunological activity of new imidazolidines against adult worms of Schistosoma mansoni. Parasitology Research 2010, 107:531-538.
17. Oliveira S.M., Albuquerque M.C.P.A., Pitta M.G.R., Malagueño E., Santana J.V., Lima M.C.A., Pitta I.R., Galdino S.L. Resposta do Schistosoma mansoni mantido in vitro frente a derivados imidazolidinônicos. Acta Farmacêutica Bonaerense 2004, 23:343-348.
18. Pechhold K., Craighead N., Wesch D., Kabelitz D. Measurement of cellular proliferation. Medical Microbiology 2002, 32:77-97.
19. Pereira V.R.A., Lorena V.M.B., Galvão da Silva A.P., Coutinho E.M., Silva E.D., Ferreira A.G.P., Miranda P., Krieger M.A., Goldenberg S., Soares M.B.P., Correa-Oliveira R., Gomes Y. Immunization with cytoplasmic repetitive antigen and flagellar repetitive antigen of Trypanosoma cruzi stimulates a cellular immune response in mice. Parasitology. 2004, 129:563-570.
20. Pica-Mattoccia L., Cioli D. Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment. International Journal for Parasitology 2004, 34:527-533.
21. Pitta, I.R., Lima, M.C., Albuquerque, M.C.P.A., Galdino, S.L., 2005. Novel compositions of imidazolidine derivatives useful in the treatment of intestinal schistosomiasis. Brazilian Patent PI, p. 25. 2005. PI-0305000-9.
22. Pitta M.G.R., Silva A.C.A., Neves J.K.A.L., Silva P.G., Irmão J.I., Malagueño E., Santana J.V., Lima M.C.A., Galdino S.L., Pitta I.R., Albuquerque M.C.P.A. New imidazolidinic bioisosters: potential candidates for antischistosomal drugs. Memórias do Instituto Oswaldo Cruz 2006, 101:313-316.
23. Rossi M.H., Zelnik R. Contribuição à química das imidazolidinadionas - síntese de ciclanilideno-hidantoínas 2000, vol. 67. Arquivos Instituto Biológico, São Paulo, pp. 125-130.
24. Sayed A.A., Simeonov A., Thomas C.J., Inglese J., Austin C.P., Williams D.L. Identification of oxadiazoles as new drug leads for the control of schistosomiasis. Nature Medicine 2008, 14:407-412.
25. Shaohong L., Kumagai T., Qinghua A., Xiaolan Y., Ohmae H., Yabu Y., Siwen L., Liyong W., Maruyama H., Ohta N. Evaluation of the anthelmintic effects of artesunate against experimental Schistosoma mansoni infection in mice using different treatment protocols. Parasitology International 2006, 55:63-68.
26. Soliman M.F.M., Ibrahim M.M. Antischistosomal action of atorvastatin alone and concurrently with medroxyprogesterone acetate on Schistosoma haematobium harboured in hamster: surface ultrastructure and parasitological study. Acta Tropica 2005, 93:1-9.
27. Thibaut J.P.B., Monteiro L.M., Leite L.C.C., Menezes C.M.S., Lima L.M., Noel F. The effects of 3-methylclonazepam on Schistosoma mansoni musculature are not mediated by benzodiazepine receptors. European Journal of Pharmacology 2009, 606:9-16.
28. Vermes I., Haanen C., Reutelingsperger C. Flow cytometry of apoptotic cell death. Journal of Immunological Methods 2000, 243:167-190.
29. Xiao S.H., Catto B.A., Webster L.T. Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo. Journal of Infectious Disease 1985, 151:1130-1137.
30. Xiao S., Binggui S., Chollet J., Tanner M. Tegumental changes in 21-day-old Schistosoma mansoni harboured in mice treated with artemether. Acta Tropica 2000, 75:341-348.
31. WHO, 1993. The control of schistosomiasis. Second report of WHO expert committee. World Health Organization, WHO Technical Report Series, Geneva, No. 830.